Walleye Trading
NKGN

Walleye Trading’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Walleye Trading’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-47,286
Closed -$488K – 5447
2023
Q2 		$488K Buy
47,286
+11,286
+31% +$116K ﹤0.01% 2767
2023
Q1 		$365K Hold
36,000
– – ﹤0.01% 3065
2022
Q4 		$358K Hold
36,000
– – ﹤0.01% 3114
2022
Q3 		$351K Hold
36,000
– – ﹤0.01% 3258
2022
Q2 		$350K Hold
36,000
– – ﹤0.01% 3269
2022
Q1 		$349K Hold
36,000
– – ﹤0.01% 3308
2021
Q4 		$349K Hold
36,000
– – ﹤0.01% 3334
2021
Q3 		$349K Buy
+36,000
New +$351K ﹤0.01% 3311

Other funds holding NKGN

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Walleye Trading's NKGN Position: Q3 2023 in Review

Walleye Trading sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q3 2023, closing a stake of 47,286 shares — an estimated $488K sold.

Walleye Trading first reported a position in NKGN in Q3 2021 and held it in 8 quarters. The position peaked at $488K in Q2 2023. 13 funds tracked by Wall St. Rank hold NKGN as of Q3 2023.

  • Walleye Trading reported no remaining NKGen Biotech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Walleye Trading sold 47,286 NKGen Biotech, Inc. Common Stock shares in Q3 2023, an estimated $488K.
  • Walleye Trading first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Walleye Trading's NKGen Biotech, Inc. Common Stock position peaked at $488K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q3 2023.

Based on Walleye Trading's 13F filing for Q3 2023, filed 14 Nov 2023.